image description
image description
Tell A Friend

FinancialNews


  • 29-07-12

    UAE's Julphar reports USD30m profit in H1

    (MENAFN) Ras AL Kaimah-based generic drug maker Gulf Pharmaceutical Industries (Julphar) reported year-on-year 8.2 percent increase in half-yearly profits, Arabian Business reported. The company said it made USD30.16 million net profit during the January-June period, with gross profit up 5.6 percent to USD103.6 million. The company also reported a 13.5 percent increase in sales to USD171.6 million during the first six months of 2012, including a 19.5 percent increase in tender market sales. The biggest sales were realized in Saudi Arabia with USD32.4 million, followed by sales in the UAE with USD17 million, and Iraq with USD15.5 million, according to Julphar's data. In terms of tender market sales, Saudi Arabia also topped Julphar's sales with USD16.9 million, followed by Iraq with USD4.84 million, and Jordan with USD4.25 million.

Follow us

RSS
Terms & Conditions  |  Privacy & Security  |  Contact Us  | Sitemap
© 2024 BBK  |  All Rights Reserved